Form SC 13G/A BRUKER CORP Filed by: MASSACHUSETTS FINANCIAL SERVICES CO /MA/
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
JPMorgan Upgrades Bruker (BRKR) to Overweight
February 13, 2024 4:24 PM ESTJPMorgan analyst Tycho W. Peterson upgraded Bruker (NASDAQ: BRKR) from Neutral to Overweight with a price target of $90.00 (from $60.00).
The analyst comments "This morning, Bruker (BRKR) reported a sizeable 4Q beat while initiating better-than-expected 2024 guidance and, most notably, pulled forward its 2026 revenue and non-GAAP EPS LRP targets to 2025 (implying >30% non-GAAP EPS growth in 2025). Strength across regions and end-markets is driven by secular trends in proteomics and other omics research in what the company describes as the... More
